{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:15:01Z","timestamp":1791152101415,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.2353\/ajpath.2006.060020","type":"journal-article","created":{"date-parts":[[2006,8,21]],"date-time":"2006-08-21T17:19:07Z","timestamp":1156180747000},"page":"655-664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Aberrant Expression of ID2, a Suppressor of B-Cell-Specific Gene Expression, in Hodgkin's Lymphoma"],"prefix":"10.1016","volume":"169","author":[{"given":"Christoph","family":"Renn\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ignacio","family":"Martin-Subero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Eickernj\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin-Leo","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"K\u00fcppers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Br\u00e4uninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2006.060020_bib1","series-title":"Hodgkin's Disease","author":"Mauch","year":"1999"},{"key":"10.2353\/ajpath.2006.060020_bib2","series-title":"Pathology of Lymphocyte Predominance Hodgkin's Disease","first-page":"168","year":"1999"},{"key":"10.2353\/ajpath.2006.060020_bib3","series-title":"Pathology of Classical Hodgkin's Disease","first-page":"101","year":"1999"},{"key":"10.2353\/ajpath.2006.060020_bib4","doi-asserted-by":"crossref","first-page":"10962","DOI":"10.1073\/pnas.91.23.10962","article-title":"Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development","volume":"91","author":"K\u00fcppers","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2006.060020_bib5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0065-230X(02)84009-X","article-title":"Molecular biology of Hodgkin's lymphoma","volume":"84","author":"K\u00fcppers","year":"2002","journal-title":"Adv Cancer Res"},{"key":"10.2353\/ajpath.2006.060020_bib6","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1073\/pnas.94.17.9337","article-title":"Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells","volume":"94","author":"Braeuninger","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2006.060020_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199708143370703","article-title":"Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells","volume":"337","author":"Marafioti","year":"1997","journal-title":"N Engl J Med"},{"key":"10.2353\/ajpath.2006.060020_bib8","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","article-title":"Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells","volume":"184","author":"Kanzler","year":"1996","journal-title":"J Exp Med"},{"key":"10.2353\/ajpath.2006.060020_bib9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cell.2004.05.014","article-title":"Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha\/beta heterodimer","volume":"117","author":"Kraus","year":"2004","journal-title":"Cell"},{"key":"10.2353\/ajpath.2006.060020_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrc1589","article-title":"Mechanisms of B-cell lymphoma pathogenesis","volume":"5","author":"K\u00fcppers","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.2353\/ajpath.2006.060020_bib11","series-title":"WHO Classification of Tumors: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"10.2353\/ajpath.2006.060020_bib12","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood-2002-03-0839","article-title":"Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","volume":"101","author":"Schwering","year":"2003","journal-title":"Blood"},{"key":"10.2353\/ajpath.2006.060020_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2003.11.008","article-title":"Transcriptional control of B cell development and function","volume":"327","author":"Bartholdy","year":"2004","journal-title":"Gene"},{"key":"10.2353\/ajpath.2006.060020_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.immunol.22.012703.104807","article-title":"Transcriptional control of early B cell development","volume":"22","author":"Busslinger","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.2353\/ajpath.2006.060020_bib15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.devcel.2004.08.006","article-title":"Assembling a gene regulatory network for specification of the B cell fate","volume":"7","author":"Medina","year":"2004","journal-title":"Dev Cell"},{"key":"10.2353\/ajpath.2006.060020_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/35105060","article-title":"The function of E- and Id proteins in lymphocyte development","volume":"1","author":"Engel","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"10.2353\/ajpath.2006.060020_bib17","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1182\/blood-2002-08-2673","article-title":"Gene expression profiling reveals a highly specialized genetic program of plasma cells","volume":"101","author":"Underhill","year":"2003","journal-title":"Blood"},{"key":"10.2353\/ajpath.2006.060020_bib18","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1074-7613(01)00153-4","article-title":"Pax5\/BSAP maintains the identity of B cells in late B lymphopoiesis","volume":"14","author":"Horcher","year":"2001","journal-title":"Immunity"},{"key":"10.2353\/ajpath.2006.060020_bib19","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/emboj\/17.8.2319","article-title":"Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments","volume":"17","author":"Nutt","year":"1998","journal-title":"EMBO J"},{"key":"10.2353\/ajpath.2006.060020_bib20","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/ni923","article-title":"E-proteins directly regulate expression of activation-induced deaminase in mature B cells","volume":"4","author":"Sayegh","year":"2003","journal-title":"Nat Immunol"},{"key":"10.2353\/ajpath.2006.060020_bib21","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1084\/jem.20031180","article-title":"Receptor editing and marginal zone B cell development are regulated by the helix-loop-helix protein, E2A","volume":"199","author":"Quong","year":"2004","journal-title":"J Exp Med"},{"key":"10.2353\/ajpath.2006.060020_bib22","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1128\/MCB.21.2.524-533.2001","article-title":"Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding","volume":"21","author":"Roberts","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.2353\/ajpath.2006.060020_bib23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrc1673","article-title":"Id family of helix-loop-helix proteins in cancer","volume":"5","author":"Perk","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.2353\/ajpath.2006.060020_bib24","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1182\/blood.V87.12.5225.bloodjournal87125225","article-title":"Id2 expression increases with differentiation of human myeloid cells","volume":"87","author":"Ishiguro","year":"1996","journal-title":"Blood"},{"key":"10.2353\/ajpath.2006.060020_bib25","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1182\/blood.V89.9.3155","article-title":"Expression of the Id family helix-loop-helix regulators during growth and development in the hematopoietic system","volume":"89","author":"Cooper","year":"1997","journal-title":"Blood"},{"key":"10.2353\/ajpath.2006.060020_bib26","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1084\/jem.192.12.1775","article-title":"Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1: evidence for a lymphoid origin of pre-DC2","volume":"192","author":"Spits","year":"2000","journal-title":"J Exp Med"},{"key":"10.2353\/ajpath.2006.060020_bib27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/ni903","article-title":"Transcriptional profiling identifies Id2 function in dendritic cell development","volume":"4","author":"Hacker","year":"2003","journal-title":"Nat Immunol"},{"key":"10.2353\/ajpath.2006.060020_bib28","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1182\/blood-2004-12-4883","article-title":"Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2","volume":"105","author":"Buitenhuis","year":"2005","journal-title":"Blood"},{"key":"10.2353\/ajpath.2006.060020_bib29","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1038\/sj.onc.1205629","article-title":"Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin\/Reed-Sternberg cells of classical Hodgkin lymphoma","volume":"21","author":"Hertel","year":"2002","journal-title":"Oncogene"},{"key":"10.2353\/ajpath.2006.060020_bib30","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1084\/jem.20030802","article-title":"The balance between Pax5 and Id2 activities is the key to AID gene expression","volume":"198","author":"Gonda","year":"2003","journal-title":"J Exp Med"},{"key":"10.2353\/ajpath.2006.060020_bib31","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1182\/blood.V94.9.3108","article-title":"Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin","volume":"94","author":"Foss","year":"1999","journal-title":"Blood"},{"key":"10.2353\/ajpath.2006.060020_bib32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00428-002-0735-5","article-title":"Expression patterns of transcription factors in progressively transformed germinal centers and Hodgkin lymphoma","volume":"442","author":"Steimle-Grauer","year":"2003","journal-title":"Virchows Arch"},{"key":"10.2353\/ajpath.2006.060020_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ni1285","article-title":"Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma","volume":"7","author":"Mathas","year":"2005","journal-title":"Nat Immunol"},{"key":"10.2353\/ajpath.2006.060020_bib34","doi-asserted-by":"crossref","first-page":"7220","DOI":"10.1158\/0008-5472.CAN-04-2095","article-title":"Id2 drives differentiation and suppresses tumor formation in the intestinal epithelium","volume":"64","author":"Russell","year":"2004","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2006.060020_bib35","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ijc.10169","article-title":"Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci","volume":"98","author":"Martin-Subero","year":"2002","journal-title":"Int J Cancer"},{"key":"10.2353\/ajpath.2006.060020_bib36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI200316624","article-title":"Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling","volume":"111","author":"K\u00fcppers","year":"2003","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2006.060020_bib37","doi-asserted-by":"crossref","first-page":"8308","DOI":"10.1038\/sj.onc.1205091","article-title":"The regulation and function of the Id proteins in lymphocyte development","volume":"20","author":"Rivera","year":"2001","journal-title":"Oncogene"},{"key":"10.2353\/ajpath.2006.060020_bib38","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1158\/0008-5472.CAN-04-2133","article-title":"Id2 is dispensable for myc-induced lymphomagenesis","volume":"64","author":"Nilsson","year":"2004","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2006.060020_bib39","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.4049\/jimmunol.168.11.5507","article-title":"Id2 negatively regulates B cell differentiation in the spleen","volume":"168","author":"Becker-Herman","year":"2002","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2006.060020_bib40","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood.V99.4.1474","article-title":"Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma","volume":"99","author":"Martin-Subero","year":"2002","journal-title":"Blood"},{"key":"10.2353\/ajpath.2006.060020_bib41","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1182\/blood.V99.4.1381","article-title":"Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2","volume":"99","author":"Joos","year":"2002","journal-title":"Blood"},{"key":"10.2353\/ajpath.2006.060020_bib42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ijc.10845","article-title":"Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2","volume":"103","author":"Joos","year":"2003","journal-title":"Int J Cancer"},{"key":"10.2353\/ajpath.2006.060020_bib43","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0002-9440(10)65424-7","article-title":"High expression of the CC chemokine TARC in Reed-Sternberg cells: a possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma","volume":"154","author":"van den Berg","year":"1999","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2006.060020_bib44","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/ijc.21716","article-title":"Molecular biology of Hodgkin's and Reed\/Sternberg cells in Hodgkin's lymphoma","volume":"118","author":"Br\u00e4uninger","year":"2006","journal-title":"Int J Cancer"},{"key":"10.2353\/ajpath.2006.060020_bib45","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM199911113412007","article-title":"Cellular origin of human B-cell lymphomas","volume":"341","author":"K\u00fcppers","year":"1999","journal-title":"N Engl J Med"},{"key":"10.2353\/ajpath.2006.060020_bib46","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/381751a0","article-title":"Clonal selection and learning in the antibody system","volume":"381","author":"Rajewsky","year":"1996","journal-title":"Nature"},{"key":"10.2353\/ajpath.2006.060020_bib47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.it.2006.03.001","article-title":"Reprogramming of the tumour B-cell phenotype in Hodgkin lymphoma","volume":"27","author":"K\u00fcppers","year":"2006","journal-title":"Trends Immunol"},{"key":"10.2353\/ajpath.2006.060020_bib48","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1182\/blood.V99.9.3398","article-title":"Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma","volume":"99","author":"Jundt","year":"2002","journal-title":"Blood"},{"key":"10.2353\/ajpath.2006.060020_bib49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ni1045","article-title":"Notch regulation of lymphocyte development and function","volume":"5","author":"Radtke","year":"2004","journal-title":"Nat Immunol"},{"key":"10.2353\/ajpath.2006.060020_bib50","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1182\/blood-2004-12-4744","article-title":"Inhibition of EBF function by active Notch signaling reveals a novel regulatory pathway in early B-cell development","volume":"106","author":"Smith","year":"2005","journal-title":"Blood"},{"key":"10.2353\/ajpath.2006.060020_bib51","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1535-6108(03)00141-7","article-title":"Id proteins in cell growth and tumorigenesis","volume":"3","author":"Sikder","year":"2003","journal-title":"Cancer Cell"},{"key":"10.2353\/ajpath.2006.060020_bib52","first-page":"301","article-title":"Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma","volume":"62","author":"Lasorella","year":"2002","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2006.060020_bib53","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/35036504","article-title":"Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins","volume":"407","author":"Lasorella","year":"2000","journal-title":"Nature"},{"key":"10.2353\/ajpath.2006.060020_bib54","first-page":"7098","article-title":"Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells","volume":"63","author":"Itahana","year":"2003","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2006.060020_bib55","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/35059131","article-title":"Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence","volume":"409","author":"Ohtani","year":"2001","journal-title":"Nature"},{"key":"10.2353\/ajpath.2006.060020_bib56","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"key":"10.2353\/ajpath.2006.060020_bib57","series-title":"Mediastinal (thymic) large B-cell lymphoma","year":"2001"},{"key":"10.2353\/ajpath.2006.060020_bib58","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2559.1993.tb00092.x","article-title":"Expression of the Ig-associated heterodimer (mb-1 and B29) in Hodgkin's disease","volume":"22","author":"Kuzu","year":"1993","journal-title":"Histopathology"},{"key":"10.2353\/ajpath.2006.060020_bib59","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/85303","article-title":"Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta","volume":"2","author":"Kee","year":"2001","journal-title":"Nat Immunol"},{"key":"10.2353\/ajpath.2006.060020_bib60","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2002-01-0099","article-title":"The role of cytokines in classical Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"key":"10.2353\/ajpath.2006.060020_bib61","first-page":"339","article-title":"The Reed-Steinberg cell: molecular characterization by proteomic analysis with therapeutic implications","volume":"32","author":"Brown","year":"2002","journal-title":"Ann Clin Lab Sci"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010627447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010627447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:53:46Z","timestamp":1762080826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010627447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0002944010627447"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2006.060020","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant Expression of ID2, a Suppressor of B-Cell-Specific Gene Expression, in Hodgkin's Lymphoma","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.2353\/ajpath.2006.060020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}